Xi I Huang

Author:

Xi Huang

ISBN #:

7539315903

US Patent:

20100204122, Aug 12, 2010

Filed:

Feb 11, 2010

Appl. No.:

12/704187

Inventors:

Xi Huang - Fair Lawn NJ, US

Assignee:

NEW YORK UNIVERSITY - New York NY

International Classification:

A61K 38/22
A61K 31/711
A61P 19/10

US Classification:

514 12, 514 44 R

Abstract:

The present invention is directed to a method of treating, preventing, or reducing the risk of bone deterioration or osteoporosis in a peri- or post-menopausal female subject. The method involves selecting a peri- or post-menopausal female subject in need of treating, preventing, or reducing the risk of bone deterioration or osteoporosis and administering hepcidin to the selected subject under conditions effective to treat, prevent, or reduce the risk of bone deterioration or osteoporosis.

US Patent:

20220409498, Dec 29, 2022

Filed:

Sep 2, 2022

Appl. No.:

17/902741

Inventors:

- New York NY, US
Xi Huang - Montvale NJ, US

International Classification:

A61K 8/19
A61Q 17/04
A61K 8/27
A61K 8/29
A61K 8/98

Abstract:

The present invention relates to a sunscreen cosmetic for application to a user's skin. The sunscreen cosmetic is provided with a mineral including zinc oxide, titanium dioxide, or a combination of both. The sunscreen cosmetic also includes a high buffering-capacity agent configured to react with an external acidic source coming in contact with the cosmetic and to inhibit release of zinc ions from the zinc oxide and/or to inhibit release of titanium ions from the titanium dioxide.

US Patent:

20220409521, Dec 29, 2022

Filed:

Sep 2, 2022

Appl. No.:

17/902742

Inventors:

- New York NY, US
Xi Huang - Montvale NJ, US

International Classification:

A61K 8/98
A61K 8/19
A61K 8/02
A61Q 1/00
A61Q 17/00

Abstract:

The present invention relates to a cosmetic for application to a user's skin. The cosmetic is provided with a colorant including iron oxides. The cosmetic also includes a high buffering-capacity agent configured to react with an external acidic source coming in contact with the cosmetic and to inhibit release of iron ions from the iron oxides.

US Patent:

20210015725, Jan 21, 2021

Filed:

Oct 2, 2020

Appl. No.:

17/062065

Inventors:

- Wilmington DE, US
Xi Huang - Montvale NJ, US

International Classification:

A61K 8/24
A61K 8/25
A61K 8/67
A61Q 19/08

Abstract:

The core active components of the present composition, termed as de-ironizing inducers (DII), has a reducing agent and a precipitating agent. Molar ratios of the reducing agent with the precipitating agent range from 1:3-6 and the core components in the skincare product range from 0.1% to 10% w/w. The pH value of the skincare product is between 6.6 and 7.4. The skin care products can safely and effectively remove iron in the skin, which has been shown to accelerate skin natural aging and photoaging. The core components can also be used in combination with conventional skincare product compounds to achieve better anti-aging effects.

US Patent:

20190091264, Mar 28, 2019

Filed:

Nov 30, 2018

Appl. No.:

16/205555

Inventors:

- New York NY, US
Ashlesha Muley - Brooklyn NY, US
Xi Huang - Montvale NJ, US

International Classification:

A61K 35/18
A61M 1/36
A61M 1/34
B01D 67/00
G01N 21/79
B01D 15/36
C12N 5/078
A61K 35/12

Abstract:

An article, system, and method is provided for the filtration of blood wherein the blood is removed, contacted with a filter substrate operatively associated with a filter structure, and the filtered blood is subsequently returned to a receiver. Methods for removing iron from the liquid fraction of blood and for determining whether a substrate is capable of selectively retaining 2,2′-dipyridyl (DP)-Fe complexes are also disclosed.

US Patent:

20160089399, Mar 31, 2016

Filed:

Apr 25, 2014

Appl. No.:

14/787214

Inventors:

Alan PERLSTEIN - Brooklyn NY, US
Ashlesha MULEY - Brooklyn NY, US
Xi HUANG - Montvale NJ, US

International Classification:

A61K 35/18
B01D 15/36
A61M 1/34
A61M 1/36
C12N 5/078
G01N 21/79

Abstract:

An article, system, and method is provided for the filtration of blood wherein the blood is removed, contacted with a filter substrate operatively associated with a filter structure, and the filtered blood is subsequently returned to a receiver. Methods for removing iron from the liquid fraction of blood and for determining whether a substrate is capable of selectively retaining 2,2′-dipyrydyl (DP)-Fe complexes are also disclosed.

US Patent:

20150024016, Jan 22, 2015

Filed:

Feb 22, 2013

Appl. No.:

14/380679

Inventors:

Xi Huang - Montvale NJ, US

International Classification:

A61K 8/67
A61Q 19/08
A61K 8/19

US Classification:

424401, 424687

Abstract:

This invention discloses a novel class of skincare products to remove iron in the skin and its preparation method. The core active components, termed as de-ironizing inducers (DII), consist of a reducing agent and a precipitating agent. The reducing agent is selected from vitamin C, vitamin E, glutathione, vitamin A, vitamin D and their derivatives. The precipitating agent is chosen from calcium carbonate, pearl powder, magnesium carbonate, barium carbonate, calcium phosphate, magnesium phosphate, barium phosphate, calcium silicate, magnesium silicate, and barium silicate. Molar ratios of the reducing agent with the precipitating agent range from 1:3-6 and the core components in the skin care product range from 5% to 10% w/w. The PH value of the skincare product is between 6.6 and 7.4. The skin care products can safely and effectively remove iron in the skin, which has been shown to accelerate skin's natural aging and photoaging.